内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by DArecca James, 首席财务官. Director active across 5 companies, notably TherapeuticsMD, Inc.. Aggregated, 16 filings have been recorded. Activity tracked since 2 May 2023. The latest transaction was filed on 4 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to DArecca James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
2,981 股0Common Stock, par value $0.01 per shareSEC:0001104659-26-091082:0
2,094 股0Common Stock, par value $0.01 per shareSEC:0001104659-25-074702:0
12,221 股0Common StockSEC:0001127602-25-016517:0
7,111 股Common StockSEC:0001127602-25-015054:0
622 股@ US$69.3821.2% 占其流量Common StockSEC:0001127602-25-014944:0
654 股@ US$63.8520.4% 占其流量Common StockSEC:0001127602-25-013343:0
2,202 股0Common Stock, par value $0.01 per shareSEC:0001104659-24-086748:0
4,439 股Common StockSEC:0001127602-24-016162:0
412 股@ US$96.4920.1% 占其流量Common StockSEC:0001127602-24-015864:0
432 股@ US$93.3320.7% 占其流量Common StockSEC:0001127602-24-014274:0
2,295 股0Common Stock, par value $0.01 per shareSEC:0001104659-23-087189:0
4,205 股Common StockSEC:0001127602-23-015929:0
430 股@ US$81.6617.6% 占其流量Common StockSEC:0001127602-23-014489:0
4,774 股Common StockSEC:0001127602-22-014966:0
5,902 股Common StockSEC:0001127602-22-013206:0
217,167 股Common StockSEC:0001387131-21-008437:0
About DArecca James
DArecca James is Directeur Financier. The record shows 15 filings in total, and the 15 sampled filings run from 2021-08-12 to 2025-08-06. The buy and sell amounts observed in this recent sample are 0 and 0, with the dominant transaction nature shown as Attribution.